Advertisement
Advertisement

APUS

A

Apimeds Pharmaceuticals US, Inc.

17.50
USD
Sponsored
+0.04
+2.34%
Mar 25, 15:58 UTC -4
Closed
exchange

Pre-Market

1.75

-15.75
-90.00%

Apimeds Pharmaceuticals US, Inc. Financial Snapshot

Market Cap
2.20M
Beta
--
Earnings Per Share (EPS)
--
Price-to-Book (P/B) Ratio
3.00
Operating Margin
--
Total Debt/Equity (D/E)
6.13%
P/E Ratio
--
Return on Equity (ROE)
-139.57%
Current Ratio
8.34%
Free Cash Flow
-5.14M

Trending Stocks

Advertisement